Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2022 Oct 31;16(10):e0010899.
doi: 10.1371/journal.pntd.0010899. eCollection 2022 Oct.

Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study

Rella Zoleko-Manego  1   2   3 , Dearie G Okwu  1 , Christian Handrich  1 , Lia B Dimessa-Mbadinga  1 , Malick A Akinosho  1 , Wilfrid F Ndzebe-Ndoumba  1 , Saskia D Davi  1   3 , Daniel Stelzl  1 , Luzia Veletzky  1   3   4 , Andrea Kreidenweiss  1   2 , Tamara Nordmann  3 , Ayola A Adegnika  1   2   5   6 , Bertrand Lell  1   4 , Peter G Kremsner  1   2   5   6 , Michael Ramharter  1   3   7 , Ghyslain Mombo-Ngoma  1   5   7   8
Affiliations
Clinical Trial

Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study

Rella Zoleko-Manego et al. PLoS Negl Trop Dis. .

Abstract

Background: Urogenital schistosomiasis is prevalent in many malaria endemic regions of sub-Saharan Africa and can lead to long-term health consequences if untreated. Antimalarial drugs used to treat uncomplicated malaria have shown to exert some activity against Schistosoma haematobium. Here, we explore the efficacy on concomitant urogenital schistosomiasis of first-line recommended artemisinin-based combination therapies (ACTs) and investigational second-generation ACTs when administered for the treatment of uncomplicated malaria in Gabon.

Methods: Microscopic determination of urogenital schistosomiasis was performed from urine samples collected from patients with confirmed uncomplicated malaria. Egg excretion reduction rate and cure rate were determined at 4-weeks and 6-weeks post-treatment with either artesunate-pyronaridine, artemether-lumefantrine, artesunate-amodiaquine or artefenomel-ferroquine.

Results: Fifty-two (16%) out of 322 malaria patients were co-infected with urogenital schistosomiasis and were treated with antimalarial drug combinations. Schistosoma haematobium egg excretion rates showed a median reduction of 100% (interquartile range (IQR), 17% to 100%) and 65% (IQR, -133% to 100%) at 4-weeks and 6-weeks post-treatment, respectively, in the artesunate-pyronaridine group (n = 20) compared to 35% (IQR, -250% to 70%) and 65% (IQR, -65% to 79%) in the artemether-lumefantrine group (n = 18). Artesunate-amodiaquine (n = 2) and artefenomel-ferroquine combination (n = 3) were not able to reduce the rate of eggs excreted in this limited number of patients. In addition, cure rates were 56% and 37% at 4- and 6-weeks post-treatment, respectively, with artesunate-pyronaridine and no cases of cure were observed for the other antimalarial combinations.

Conclusions: Antimalarial treatments with artesunate-pyronaridine and artemether-lumefantrine reduced the excretion of S. haematobium eggs, comforting the hypothesis that antimalarial drugs could play a role in the control of schistosomiasis.

Trial registration: This trial is registered with clinicaltrials.gov, under the Identifier NCT04264130.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Participants flow.
Abbreviation: Tx: treatment.
Fig 2
Fig 2. Schistosoma egg excression before and posttreatment.
See this image and copyright information in PMC

References

    1. WHO | What is schistosomiasis? [Internet]. WHO. [cited 19 May 2020]. Available on: http://www.who.int/schistosomiasis/disease/en/
    1. Wikman-Jorgensen PE, Henríquez-Camacho CA, Serrano-Villar S, Pérez-Molina JA. The role of artesunate for the treatment of urinary schistosomiasis in schoolchildren: a systematic review and meta-analysis. Pathog Glob Health. Nov 2012;106(7):397–404. doi: 10.1179/2047773212Y.0000000038 - DOI - PMC - PubMed
    1. Schistosomiasis [Internet]. [cited 19 May 2020]. Available on: https://www.who.int/news-room/fact-sheets/detail/schistosomiasis
    1. Adegnika AA, Ramharter M, Agnandji ST, Ateba Ngoa U, Issifou S, Yazdanbahksh M, et al.. Epidemiology of parasitic co-infections during pregnancy in Lambaréné, Gabon. Trop Med Int Health TM IH. oct 2010;15(10):1204–9. doi: 10.1111/j.1365-3156.2010.02598.x - DOI - PubMed
    1. Dejon-Agobé JC, Edoa JR, Honkpehedji YJ, Zinsou JF, Adégbitè BR, Mbong Ngwese, et al.. Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon [published correction appears in Parasit Vectors. 2021 Jun 21;14(1):329]. Parasit Vectors. 2019;12(1):577. Published 2019 Dec 10. doi: 10.1186/s13071-019-3836-6 - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data